SCHEMBL5674741

SCHEMBL5674741

CC(C)Oc1ccccc1C1(N[C@H](CO)c2ccccc2)C(=O)Nc2ccc(Cl)cc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 6/20 0.47
▸ GAA P10253 1/20 0.38
▸ IDO1 P14902 2/20 0.37
▸ BRD2 P25440 1/20 0.36
▸ BRD3 Q15059 1/20 0.36
▸ BRDT Q58F21 1/20 0.36
▸ FGFR1 P11362 1/20 0.35
▸ FGFR2 P21802 1/20 0.35
▸ FGFR3 P22607 1/20 0.35
▸ PHGDH O43175 1/20 0.35
▸ CBX7 O95931 1/20 0.35
▸ CDYL Q9Y232 1/20 0.35
▸ ADCY8 P40145 1/20 0.34
▸ ADRB3 P13945 1/20 0.34
▸ SNRNP200 O75643 1/20 0.34
▸ TSPO P30536 1/20 0.33
▸ PAK4 O96013 1/20 0.33
▸ ELOVL6 Q9H5J4 1/20 0.33
▸ MAP2 P11137 1/20 0.33
▸ MDM2 Q00987 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27511771 0.90 BRD4 (0.48) BRD4IDO1FGFR1FGFR2FGFR3
SCHEMBL5674067 0.90 BRD4 (0.48) BRD4IDO1FGFR1FGFR2FGFR3
SCHEMBL9283365 0.85 BRD4 (0.49) BRD4GAAIDO1BRD2BRD3
SCHEMBL7471456 0.85 BRD4 (0.49) BRD4GAAIDO1BRD2BRD3
SCHEMBL7471316 0.85 BRD4 (0.49) BRD4GAAIDO1BRD2BRD3
SCHEMBL5677834 0.76 KMT2A (0.53) BRD4GAAIDO1CBX7CDYL
SCHEMBL5678936 0.75 IDO1 (0.46) BRD4GAAIDO1CBX7CDYL
SCHEMBL5674439 0.74 GAA (0.43) GAAIDO1CBX7CDYLADCY8
SCHEMBL5674767 0.74 BRD4 (0.41) BRD4
SCHEMBL5675223 0.74 GAA (0.43) GAAIDO1CBX7CDYLADCY8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7119086-B2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use SANOFI-AVENTIS (FR) 2006-10-10 — — US disclosed
EP-1419150-B1 PHENYLSULFONYL-1,3-DIHYDRO-2H-INDOLE-2-ONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE SANOFI AVENTIS (FR) 2005-04-27 — — EP disclosed
US-20040180878-A1 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use SANOFI-AVENTIS (FR) 2004-09-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040180878-A1 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use AVPR2, AVPR1A, AVPR1B BRD4 2751/4885GAA 4735/4885IDO1 86/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback